These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 463668)

  • 1. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. 2. Characteristics of a metastasizing variant of a chemically induced lymphoma.
    Schirrmacher V; Shantz G
    Adv Exp Med Biol; 1979; 114():769-75. PubMed ID: 463668
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo.
    Schirrmacher V; Shantz G; Clauer K; Komitowski D; Zimmermann HP; Lohmann-Matthes ML
    Int J Cancer; 1979 Feb; 23(2):233-44. PubMed ID: 761943
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.
    Schirrmacher V; Bosslet K; Shantz G; Clauer K; Hübsch D
    Int J Cancer; 1979 Feb; 23(2):245-52. PubMed ID: 83969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro.
    Bosslet K; Schirrmacher V; Shantz G
    Int J Cancer; 1979 Sep; 24(3):303-13. PubMed ID: 314938
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 7. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of macrophage tumor cytostasis by tumor-induced ascites.
    Gemsa D; Kramer W; Napierski I; Bärlin E; Till G; Resch K
    J Immunol; 1981 Jun; 126(6):2143-50. PubMed ID: 7229369
    [No Abstract]   [Full Text] [Related]  

  • 9. Tumor-specific and allospecific immunogenicity of soluble extracts from chemically induced murine sarcomas.
    Pellis NR; Tom BH; Kahan BD
    J Immunol; 1974 Aug; 113(2):708-11. PubMed ID: 4136043
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens.
    Brannen GE; Adams JS; Santos GW
    J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: Correlation with metastic capacity.
    Davey GC; Currie GA; Alexander P
    Br J Cancer; 1976 Jan; 33(1):9-14. PubMed ID: 1252330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of macrophages in tumour immunity. 3. Co-operation between macrophages and lymphoid factors in an in vitro allograft situation.
    Evans R; Grant CK
    Immunology; 1972 Nov; 23(5):677-87. PubMed ID: 4673868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
    Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
    J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
    [No Abstract]   [Full Text] [Related]  

  • 15. F1 resistance to AKR lymphoma cells in vivo and in vitro.
    Schmitt-Verhulst A-M ; Zatz MM
    J Immunol; 1977 Jan; 118(1):330-3. PubMed ID: 830755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunological response in the mouse brain: I. Transplantation immunity to mouse lymphoma graft.
    Keyaki A; Handa H; Yamashita J; Kuribayashi K; Masuda T
    Nihon Geka Hokan; 1988 May; 57(3):191-201. PubMed ID: 3248016
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant.
    Altevogt P; Kurnick JT; Kimura AK; Bosslet K; Schirrmacher V
    Eur J Immunol; 1982 Apr; 12(4):300-7. PubMed ID: 6124426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Demonstration of the antitumour effect of in vivo macrophage activation.
    Parr I
    Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4607926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.